Roth MKM lowered the firm’s price target on MGP Ingredients (MGPI) to $50 from $60 but keeps a Buy rating on the shares. The company’s results were in line with its pre-announcement issued last October, and while the management’s outlook for 2025 is below estimates, it is not as negative as feared, the analyst tells investors in a research note. MGP Ingredients is taking appropriate steps to optimize efficiency in the face of revenue headwinds, while prudently investing for future growth, Roth adds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGPI:
- MGP Ingredients Faces Potential Legal Challenges: Implications for Financial Health and Operations
- MGP Ingredients Reports 2024 Financial Results Amid Industry Challenges
- Morning Movers: TJX and Lowe’s gain following fourth quarter results
- MGP Ingredients files to sell 4.89M shares of common stock for holders
- MGP Ingredients sees FY25 EPS $2.45-$2.75 , consensus $3.46